Reddit Posts
While the FSR and BOWL guys try to pump their flat tires, OMGA up 15% today
Congratulations to those who listened to me on CYTK. Ultra super duper RIP to shorts there. Rolled my profits into OMGA
MRNA Stock is Rising, Sales Fell a Bit Less Than Expected in 2023 (Barron's)
Will Moderna (MRNA) ever regain its Sept 2021 value and potentially exceed it?
Will Moderna (MRNA) ever regain its Sept 2021 value and potentially exceed it?
Does FSR really look like a buy or YOLO?
Wash your hands you dirty degenerates. MRNA gains
Technical Analysis: The Bullish Case for MRNA’s Inverted Scallop
Cup and Handle, MRNA breakout (Gann Fans included)
Thoughts on these tickers for bagholding throughout 2024? 💰
Moderna’s Stock Boosted by Data From Trial of Melanoma Treatment for NASDAQ:MRNA by DEXWireNews
$RNXT $1.00 +25.63% #Cancer #Treatment #Research
Moderna - headed back to pre-Covid levels?
currently long some MRNA 70 puts expiring June 24 (trade management question)
CDC: New Variant BA.2.86 More Capable of Causing Infection In Those Previously Vaccinated or Infected
Looks like MRNA calls are back on the table again…..
Post-COVID Era Plays (Lessons from $PFE earnings)
what does it mean if a company has over 100% institutional ownership
All in $MRNA. This is ready for some lift
MRNA Strong-Buy, wondering where I'm going wrong with this.
Bull Thesis for Dr Reddy’s Laboratories (NYSE: RDY)
$219k in MRNA stock, up around 4% today, technical analysis comments anyone?
$219k in MRNA stock up about 4% today. To the fking moon ape brothers 💎🚀💰 ✊🏻
Johnson & Johnson Earnings Are Here: Should You Buy?
Tiziana Life Sciences $TLSA is Bracing for an Explosive 2023
The Catalysts Behind Tiziana Life Sciences' (NASDAQ: TLSA) 70%
2023-04-03 Wrinkle Brain Plays - In the style of Count Dracula
This seems big: Generation Bio will receive a $40 million upfront cash payment, a pre-payment of research funding, plus a $36 million equity investment from Moderna, with the potential for additional milestones, fees, and royalties. It doesn't look shorted but seemed worth reading IMHO
Moderna eyes $130 price tag for COVID vaccine shot in US - report (MRNA)
2023-03-20 Wrinkle-brain Plays (Mathematically derived options plays)
Revolutionizing Healthcare with Galileo Life Science: Exploring the Future of Tele-Health Service
Nvax heavily shorted, will it bounce again ? I just went in with some shares. I know covid is over, lot of mRNA injured people. Elon Musk.
Opinions on Moderna (MRNA) vs BioNTech (BNTX)?
COVID vaccine sales to see decline through end of decade as pandemic eases (MRNA)
Highly Anticipated Earnings 2/21-2/24 🚨 Some big names for the week - $COIN $NVDA $BABA $LCID $MRNA $EBAY
2023-02-15 Wrinkle-brain Plays (Mathematically derived options plays)
want to leverage short MRNA, how to take advantage of the call skew on leaps?
2023-02-01 Wrinkle-brain Plays (Mathematically derived options plays)
Sens. Warren, Welch urge Moderna to reconsider COVID-19 shot price increase (NASDAQ:MRNA)
Thoughts on shorting MRNA and PFE
Ctmx (Cytomx Therapeutics) announced collobaration with MRNA (Moderna). Will it Squeeze?
""Moderna #MRNA signs $35 million deal with cancer drug developer 👉CytomX #CTMX!"👈🚀🔥!!
"Moderna #MRNA signs $35 million deal with cancer drug developer 👉CytomX #CTMX!"👈🚀🔥!!
"Moderna #MRNA signs $35 million deal with cancer drug developer 👉CytomX #CTMX!"👈🚀🔥!!
Annualized Return of Portfolio seem too optimistic, where am I going wrong?
Insider Trading Weekly Update #019: 8-Figure Dave And Busters Buys, Largest Trades + Sector and Market Cap Overviews From The Past Week
Insider Trading Weekly Update #019: 7+ Figure D&B/Duolingo Purchases, Largest Trades + Sector and Market Cap Overviews From The Past Week
Could it be that this system is completely fraudulent?
Did quite well on $MRNA today. Was able to break even with a good amount of profit. Any thoughts? News? Maybe some squeeze available, you tell me….
$MRNA $MRNA - woke up like dis. can finally buy out of this dumb fucking stock. At least going out with some gains dough….
Pfizer, Phizer announcement made for China, I told WSB it was coming commenters didn't listen
MTNB: Undervalued for its flexible drug delivery platform
MRNA Vaccines Ineffective VS. New Variants - PFE BNTX 🚀🚀🚀
Analyst bearish call well before the move. MRNA. That's 1 out of 10,000 odds. "so called analyst " are usually way behind and well off on their price targets.
$90k loss porn, wrecked my portfolio on NFLX and MRNA weekly options, I was up about $20k then turned red. Can I get a refund?
What do we all think of the news from SBFM this morning? (MRNA Cancer News)
Brokerage and/or personal performance review suggestions
2022-11-01 Wrinkle-brain Plays (Mathematically derived options plays)
Overly inflated stocks that could easily drop 50%+ in the coming months...which ones?
Overly inflated stocks that could easily drop 50%+ in the coming months...which ones?
Overly inflated stocks that could easily drop at least 50% in the coming months...which ones?
BREAKING: After 150 days, the vaccine effectiveness (VE) of 3 doses of Moderna turns negative
$MRNA Joe Biden says the COVID-19 pandemic is over. After breakdown 140 zone , now we ca go to 115 lvl june lows, #doublebottom #markets #stocks $SPX
$EVAX $2.50 Biotech (Denmark) may be on verge of MRNA based Gonorrhea vaccine using AI platform
NASDAQ 100 vs. Individual Components of the NASDAQ 100 for the next decade
2 Fast 2 VERUious - The pharma value + short squeeze play
Moderna COVID vaccine sales forecast unchanged even as COVAX program cuts orders
Monkeypox is Covid 2.0 and I’m going to shame the 🌈 🐻 by making so much money
Monkeypox is Covid 2.0 and I’m going to shame the 🌈 🐻 by making so much money
Mentions
I really, really miss making money on MRNA, NVAX and Vaxart.
LLY is >$200B over valued. Them and NVO gonna be the next PFE/MRNA. Not ok to inject this shit and f’up your digestive system. Lawsuits will come.
MRNA has failed for 15 years to make their tech useful. 1 vaccine will not save them.
Bought MRNA puts at 1.04, sold at 2.70 (peaked 4.50 that day). The aapl calls I sold at 100% profit are up over 850%
What was up with the 3:16 spike yesterday? Its not on everything, but SNPS, MRNA and CRSP (CRSP went from 61.90 to 65.19 and back) and a few others had big spikes for a minute or two then went back down to where they were trading. Im looking at yahoo finance charts for reference. Note I dont think its some huge conspiracy sky is falling manipulation, just curious.
SBNY, UPST, and MRNA. Lost so much that it’s not even worth selling lol
Cuz all those companies are also gonna be sued for that MRNA Covid-19 shit they also developed, actually giving people cancer....
Your DD is heavily based on market cap of each virus. This is not a realistic approach, as barely a tiny portion would be captured, if the vaccine ever rolled out. Take VZV for example, the current commercial vaccine has 90% efficiency and it costs nothing to produce and ship. Even if Modernas was 100% effective, the logistics behind an MRNA vaccince are making it not worth it. I would just remove those 5b marketcap from your DD.
MRNA massive boner.. looks like we're going into lockdown 3.0
Did MRNA cure cancer or what?
MRNA loves mooning 10% randomly
MRNA shrek only ![img](emote|t5_2th52|4276)
see my previous post + about 30 shares. Timeline? I don't know. could compare with MRNA and NVAX for that
What the fuck is going on with MRNA?
I know Stocktwits is full of morons but the amount of regards in the MRNA channel is wild. Full on brain rot with these folks and vaccine conspiracy theories. I wish COVID knocked off more of these idiots
MRNA can suck all of my dick. This stairs up, elevator down shit is infuriating
Removed. We get you're I to MRNA, we don't need another post from you every day about it esp just posting a link.
The move on MRNA was overshadowed by RDDT, but ya couldn't ask for a better start after I posted this. Getting interesting. https://preview.redd.it/lsiblqbuyjqc1.png?width=2124&format=png&auto=webp&s=6bce2f369a4c9607616094608649517d5efced37
MRNA doesn’t move like this unless there’s something big coming
MRNA made me a shit ton of money today TY!
No for real though, MRNA looking explosive. Something going on. Prob big news soon
MRNA kinda flying. DWAC wildin out. SEED shares gonna double or triple in coming weeks too
DWAC calls, MRNA calls, SEED shares
MRNA calls. Cathie buying huge lately.
Cathie out here buying fat blocks of MRNA. Calls
Unironically, some of the weed stocks that are significantly under book value right now imo. TLRY and SNDL are both at around half their BOOK value with an obscene amount of tailwinds coming up this year. There’s some other beaten down bios and whatnot that could still do well in a broad market pullback.. strong ones like MRNA come to mind. The AI bubble is going to have major issues once NVDA fails to hold 1k imo.
You are doing great job, ignore negatives, keep focusing what you have done and what you are doing. The reason: I did not post (vexed) many times about MRNA, but started investing MRNA from $16 onwards...until $128 pre-covid times. Sold most of them when it was around $400+ range, waiting for many months/years to see MRNA touched $65. Now, started accumulating the company from $76 onwards slowly whenever I get some extra cash.
As a physician investor, I'm not putting money in MRNA. It was a good short term play on the covid panic, but I cashed out a little after the vaccine came out. mRNA tech is going to have some uses that make sense. Cancer treatments come to mind, where the risk clearly is outweighed by the benefit. But this tech comes with its own (very poorly studied for political reasons) problems. In the end, we will see that this tech increases risk of autoimmune disease and cancers. Probably small risk, but likely dose and frequency dependent. As such, it will have a more limited desired use than everybody is thinking right now.
I’m surprised the two first comments to OP are superficial negatives without anything more. I’m also interested in MRNA. Not sure how the two negative comments can square the fact of: MRNA 2020: 11 preclinical, 8 Phase 1, 4 Phase 2, and 1 Phase 3 (25 development programs) MRNA 2023: 6 preclinical, 22 Phase 1, 7 Phase 2, 5 Phase 3 (43 development programs) That’s beyond incredible.
With MRNA, we are buying the rumor. They are a “Covid Stock” until they develop another product. The counter narrative to that is they knocked it out of the park with their first product and the technology behind that is extremely new and innovative. Their stage 3 clinical trials have looked especially promising with a 50% reduction in reoccurrences in cases of melanoma.
Also, this is PFE is obviously the value trade and MRNA is the epitome of growth…so they’re really in two different spaces depending on your risk tolerance. WBA has looked cheap for years if you want an example of a stock with good price to earnings that has been a complete value trap.
I keep it on my watchlist for comparison. For context, PFZ showed no sign of reversal when I made my initial post in November, while MRNA was flashing bullish divergence on longer term charts. So, I will have to take a harder look, but I don’t necessarily disagree with your premise because I haven’t done a complete examination.
Compare PFE’s price action to MRNA since November and get back to me.
Cathie buying up shit tons of MRNA. Big conference they’re presenting company updates next week. Buying April $115-120 calls
MRNA on an uptrend. Buying calls
MRNA has had a few disasters out there in terms of trials.. My guess Is this is a marketing post.
short version : MRNA tech can be used to treat/prevent probably 100s of illnesses. Moderna was on track to phase 3 multiple new drugs when covid started, they released it would work for covid and put everything else on the back burner because the covid vaccine took up all their resources. now that covid is "over" they are restarting all the process for the other drugs. RSV vaccine this year.. more next year, many more the year after. the company is just getting started.
I believe in the fundamentals, price action and technology of this company. The short float is just an added bonus from short sellers who think of this as just a COVID stock...[https://www.marketbeat.com/stocks/NASDAQ/MRNA/short-interest/](https://www.marketbeat.com/stocks/NASDAQ/MRNA/short-interest/)
guh I guess i'lll never buy MRNA now... fucking bimbo ruins everything
MRNA and BB calls. Obviously DWAC too
Own DWAC calls, buying MRNA calls
I am bearish on MRNA since a situation like Covid is once in a lifetime. There are other diseases to cure, but they will not generate the revenues for MRNA like in 2021 and 2022.
Step 1: go to every CVS in my area tryna get boosted so that I can boost $MRNA stock price. Step 2: calls Step3 : profit
Im up to 7-8 people i know getting cancer soon right after that awesome product that PFZR and MRNA dropped
Serious Question, how many people do you know that got the Turbo Cancer after the whole $MRNA product release party a few years ago.
Bro i remember early pandemic, suited up head to toe in PPI trying to intubate this poor fucker in resp arrest and thinking to myself "those MRNA calls better fuckin print"
blindly buy BIIB $PFE #Roche $MRNA $BNTX $BMY, got it thanks dad
Therefore, one shoul buy oversold and undervalued healthcare stocks... like $BIIB $PFE #Roche $MRNA $BNTX $BMY... and short the bubble of the semi, go long $SOXS hahaha
MRNA, these guys will cure cancers, I don’t even care how the share price performs
MRNA is interesting but very risky, and could be overvalued one way or another, coming down from pandemic heights. Lily and Novo Nordisk are in hype. Bayer fell hard. Smaller biotechs are and have been struggling and the big pharma that can afford it are buying assets left and right. Generics and Biosimilar manufacturers are doing ok, but that‘s not a high-reward environment. As a whole I‘d argue pharma is risky yet with potential as usual.
I don't trade options, but I rebalanced my stock portfolio, sold a bit of COIN and MRNA as I feel they're close to capping. I rebalanced to (total) 20% HOOD at open this morning. Price target 58ish give or take imo.
Tech is undervalued. People are overvalued. Puts on MRNA.
i was going to buy some MRNA longs when i woke up. i woke up at 8, then decided i could sleep in because i didn't have work today, and within the span of 3 hours its FUCKING +8% ALREADY JUST KILL ME WHAT THE HELL AAAAAAAAAAAAA FUUUUCKKKK
MRNA is killing it with their vaccines today
What’s up with MRNA? my calls I wrote off as worthless are now up 1000% today
MRNA ![img](emote|t5_2th52|4276)![img](emote|t5_2th52|4276)![img](emote|t5_2th52|4276)
I definitely see a 10 % haircut, but it is coming at different times in different segments. COSTCO and NVDA just took a 6%. AMD took 3.13 %. BBY TGT MRNA will take 3-5% cuts this week. A lot of froth out there…. CVNA NEEDS A GOOD 10% cut… so does GM, PG, ENPH, JNJ and big oil. I don’t think it will be a perfect 10% all at once but over a few weeks some chips will be taken off the table. I short the rip and sell the dip. Been pretty good so far.
it's peak 2022 Meme-METAVERSE-MRNA-THEN BACK TO MEME TOWEL-AI stock. What a time to live
MRNA breakout ![img](emote|t5_2th52|4276)
The first options I traded was some weird little biotech company back in 2018. MRNA.
My approach to this: continue to invest in index funds, being sure to choose very-low-cost funds. Supplement (not replace) that with investments into companies I have carefully researched. Invest things like bonuses into a handful of these companies with the expectation that they will outperform the index over time. If you get lucky, they will outperform and that outperformance will give you an NVDA or NFLX. But the idea very much is to buy with the intent of never selling unless management goes off the rails. The thing about finding 10-baggers is it's a hit-or-miss project. But as you have seen, one or two can really change the overall trajectory of your portfolio. It takes work and luck to find them, but there are often clues. Steve Jobs returning to Apple and then launching iPod and iMac, for example. Nadella taking over at MSFT and focusing on cloud. TSLA positioning to soak up all the green credits the US government could issue. MRNA getting an EUA for its Covid vaccine in 2020. You just don't go all-on on any of these because they can just as easily underperform or go to zero. Psychologically, having some NFLX/NVDA/AAPL helps keep you interested, and if you choose well those plus your index funds will comprise a portfolio that outperforms the market.
I sold my 6 MRNA shares I had for 420.69. It's close to their all time high.
I bought 100 shares of MRNA for $17 and sold at $23...got to $495
What’s with the shit attitude on this sub? SPY did 100% in last five years, AAPL 331%, NVDA almost 2,000%, WALMART 92%, CAT 172%, MRNA 378%, etc etc…. It’s not about the RIGHT STOCKS…it’s about almost any legit company that isn’t a penny stock or some obscure company losing money constantly. Why such a pessimistic attitude? Do you guys really suck that bad at investing? PLUG POWER has still done over 100% in five years even though it hit $60/share and is now trading at like $3/share in the same time frame. If it was back at ATH you’d be up thousands of %%%
For my BISHES: MW Nvidia's next mission: Make even more financial history 03/02/24 5:31 AM No company has ever posted financial results quite like Nvidia's, but that just means Wall Street now expects the Silicon Valley chip maker to do something else that has never been done Nvidia Corp. has just given the world the details of its historic financial year. Its reward: Expectations that the chip maker will accomplish something that has never been done before. When Nvidia (NVDA) wrapped up its fiscal year with an earnings report last week, the astounding numbers sent the stock to records and boosted indexes to their own all-time highs. The market capitalization of the company is hovering around $2 trillion and its stock has increased by nearly 1,900% in the last five years. But if you think closely about a few of the numbers that were included in Nvidia's recent financial report, you will realize just how incredible Nvidia's last financial year turned out. It really is one for the record books. Nvidia in its 2024 fiscal year produced profit of $29.76 billion, a feat in and of itself. But that number is even more mind-blowing when compared with Nvidia's past performance: The chip maker had never produced an annual revenue total that high in its 25 years as a public company, with sales topping out the previous year at $26.97 billion. The Dow Jones Market Data team crunched the data on those 25 years and discovered that no company had ever accomplished that feat at Nvidia's scale. Since 1999, nearly 300 companies had produced profits that were higher than any previous revenue total, but most were much smaller companies that produced profit of less than $1 billion in their record years. More from Jeremy: Will Nvidia stock be more like Apple or Cisco in the AI era? Previously, the highest profit total that exceeded any previous revenue total belonged to Moderna Inc. (MRNA) The vaccine maker produced profit of $12.2 billion in 2021 after introducing its COVID-19 vaccine, but that profit was less than half of what Nvidia put up last year. Only three other companies surpassed $10 billion in accomplishing the feat: Another vaccine maker, BioNTech SE (BNTX), in 2021; Gilead Sciences (GILD) in 2014, thanks to Sovaldi; and Charter Communications Inc. (CHTR) in 2009, which was largely a paper profit that resulted from exiting a bankruptcy exit. There is a chance that Nvidia's record doesn't stand for long, because it could fall just this year. But it would be Nvidia that breaks it - after putting up sales of $60.9 billion last year, Wall Street expects profit of nearly $56 billion this year. And analysts' projections have steadily come in lower than Nvidia's actual performance in recent quarters. Those earnings expectations stand out in another way, though. After last week's blowout earnings report, analysts' forecasts increased to the point that Wall Street now expects Nvidia to surpass $100 billion in revenue this year, a barrier even Intel Corp. (INTC) has never broken. Opinion: Nvidia is seeing a generative-AI boom, but don't bet on it spreading to the rest of tech When we put the revenue and profit expectations together, something stands out - the margin. Wall Street expects Nvidia to take home more than 50 cents of every dollar it collects in net income this year, which would establish a record that doesn't need the "at that scale" qualifier. Dow Jones Market Data combed through financial records dating back to 1999, and found no companies that have ever produced $100 billion in revenue with a net profit margin greater than 50%. If Nvidia lives up to - or beats - Wall Street's expectations, it would be the first company to ever accomplish that feat. For more on how Nvidia reached this point, and what it means for the market, listen to this week's On Watch by MarketWatch podcast. Check out On Watch by MarketWatch, a weekly podcast about the financial news we're all watching, and how it affects your wallet. MarketWatch's Jeremy Owens trains his eye on what's driving markets and offers insights that will help you make more informed money decisions. Subscribe on Spotify and Apple. -Jeremy C. Owens This content was created by MarketWatch, which is operated by Dow Jones & Co.
NVDA and MRNA both rocketed when added.
MW Nvidia's next mission: Make even more financial history 03/02/24 5:31 AM No company has ever posted financial results quite like Nvidia's, but that just means Wall Street now expects the Silicon Valley chip maker to do something else that has never been done Nvidia Corp. has just given the world the details of its historic financial year. Its reward: Expectations that the chip maker will accomplish something that has never been done before. When Nvidia (NVDA) wrapped up its fiscal year with an earnings report last week, the astounding numbers sent the stock to records and boosted indexes to their own all-time highs. The market capitalization of the company is hovering around $2 trillion and its stock has increased by nearly 1,900% in the last five years. But if you think closely about a few of the numbers that were included in Nvidia's recent financial report, you will realize just how incredible Nvidia's last financial year turned out. It really is one for the record books. Nvidia in its 2024 fiscal year produced profit of $29.76 billion, a feat in and of itself. But that number is even more mind-blowing when compared with Nvidia's past performance: The chip maker had never produced an annual revenue total that high in its 25 years as a public company, with sales topping out the previous year at $26.97 billion. The Dow Jones Market Data team crunched the data on those 25 years and discovered that no company had ever accomplished that feat at Nvidia's scale. Since 1999, nearly 300 companies had produced profits that were higher than any previous revenue total, but most were much smaller companies that produced profit of less than $1 billion in their record years. More from Jeremy: Will Nvidia stock be more like Apple or Cisco in the AI era? Previously, the highest profit total that exceeded any previous revenue total belonged to Moderna Inc. (MRNA) The vaccine maker produced profit of $12.2 billion in 2021 after introducing its COVID-19 vaccine, but that profit was less than half of what Nvidia put up last year. Only three other companies surpassed $10 billion in accomplishing the feat: Another vaccine maker, BioNTech SE (BNTX), in 2021; Gilead Sciences (GILD) in 2014, thanks to Sovaldi; and Charter Communications Inc. (CHTR) in 2009, which was largely a paper profit that resulted from exiting a bankruptcy exit. There is a chance that Nvidia's record doesn't stand for long, because it could fall just this year. But it would be Nvidia that breaks it - after putting up sales of $60.9 billion last year, Wall Street expects profit of nearly $56 billion this year. And analysts' projections have steadily come in lower than Nvidia's actual performance in recent quarters. Those earnings expectations stand out in another way, though. After last week's blowout earnings report, analysts' forecasts increased to the point that Wall Street now expects Nvidia to surpass $100 billion in revenue this year, a barrier even Intel Corp. (INTC) has never broken. Opinion: Nvidia is seeing a generative-AI boom, but don't bet on it spreading to the rest of tech When we put the revenue and profit expectations together, something stands out - the margin. Wall Street expects Nvidia to take home more than 50 cents of every dollar it collects in net income this year, which would establish a record that doesn't need the "at that scale" qualifier. Dow Jones Market Data combed through financial records dating back to 1999, and found no companies that have ever produced $100 billion in revenue with a net profit margin greater than 50%. If Nvidia lives up to - or beats - Wall Street's expectations, it would be the first company to ever accomplish that feat. For more on how Nvidia reached this point, and what it means for the market, listen to this week's On Watch by MarketWatch podcast. Check out On Watch by MarketWatch, a weekly podcast about the financial news we're all watching, and how it affects your wallet. MarketWatch's Jeremy Owens trains his eye on what's driving markets and offers insights that will help you make more informed money decisions. Subscribe on Spotify and Apple. -Jeremy C. Owens This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
This has been my experience as well, with the exception of MRNA which kept running. SMCI isn't a normal stock though, so who knows.
Just as the physical COVID virus attack would get me to buy MRNA so as a digital virus attack would get me to but PANW.
Weird my aunt developed rare blood cancer after 3x covid vaccines and 2x covid infection >Nearly 3,000 people are suspected of suffering from leukemia after receiving the domestically produced COVID-19 vaccine >https://www.rfa.org/cantonese/news/covid-02272024114405.html (translate) MRNA 20
I got started on Robinhood, added $10 to my fund and they gave me a free stock…MRNA. Sold it at $14 right before Covid hit.
$180 AMD calls and $104 MRNA calls... sold a little early but profit is profit. I you're honestly better off just trading SPY as a noob trader. Most of my places boil down to a hunch, or instinct instead of "DD" or TA. It's just gambling![img](emote|t5_2th52|8882)
MRNA earnings was feb 22 ???![img](emote|t5_2th52|4275)![img](emote|t5_2th52|4275)![img](emote|t5_2th52|4275)
Not to be overlooked by AI , but MRNA is up nearly 15% 🎉
Is MRNA going to fall or not wtf??
Everyone sleeping on MRNA who dumped a few days ago for no fucking reason whatsoever, and now is pumping to infinity.
MRNA earnings are today
Can someone tell me about MRNA
Bing projects $MRNA to drop below $60 by end of month "based on activity in the options market". I'm puzzled to see this clear direction with narrow confidence bands. Thoughts? (not allowed to post a discussion) ​ https://preview.redd.it/bnqv79ph34kc1.png?width=1513&format=png&auto=webp&s=a682c93de0a91738eb90a94e3c52f52ffd54b547
Wtf is MRNA sounds like a fake company.
No way I’m the only one holding MRNA puts for earnings tomorrow. I haven’t seen much talk other than the chip stocks. Kinda makes me feel good about em.
Looking at puts for $NKLA and $MRNA pre and $CVNA and $BKNG post
All my earnings plays went well, I just need MRNA to shit the bed tomorrow
MRNA calls for earnings tmr morning so regarded it just may work
RIVN ETSY MRNA and LCID AH, inverse image for NVDA https://preview.redd.it/p0lqf9idazjc1.png?width=269&format=png&auto=webp&s=bb31a61b2e40ed5c37297900fecc296421b8538e